Takara Bio USA, Inc.’s Post

Unlocking biological insights with single-cell profiling? Register below 👇 and discover how Shasta™ technologies enable high-throughput #singlecell analysis to uncover new #biomarkers of health and disease.

💡𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Prof. Andrew Beggs shares his expert insights on how key advancements are shaping the future of bowel cancer research and genomic data analysis in clinical practice. In the interview, Prof. Beggs discusses how his team explores cfDNA for real-time tumor monitoring and resistance mutation detection using cutting-edge technology. Also, how they are using AI machine learning and multiomics. He moves on to speak about technologies like Oxford Nanopore Technologies longread sequencing which is becoming more accurate and affordable, and the miniaturization of sequencing devices.  💥Thanking Prof. A. Beggs for his valuable insights. Full article here - https://lnkd.in/dUe6zECj #PrecisionMedicine #Genomics #BowelCancer #AIinHealthcare #LongReadSequencing #cfDNA #Multiomics

Explore how microfluidics is revolutionizing genomic analysis. This e-book dives into its impact on PCR and NGS library preparation, highlighting benefits like cost savings and automation. See applications in pharmacogenomics and cancer genomics through compelling case studies.

Our paper "DeMoS: Dense Module based Gene Signature Detection through Quasi-Clique: An Application to Cervical Cancer Prognosis" is accepted in Network Modeling Analysis in Health Informatics and Bioinformatics (NHIB), Springer. Suparna Saha, Soumita Seth, Soumadip Ghosh, Guimin Qin, Tapas Bhadra, Soumen Kumar Pati, Somenath Chakraborty, Saurav Mallik*, "DeMoS: Dense Module based Gene Signature Detection through Quasi-Clique: An Application to Cervical Cancer Prognosis", Network Modeling Analysis in Health Informatics and Bioinformatics (NHIB), Springer, 2024 (accepted) [Impact Factor: 2.3].

📢News Release - SVDuo™ – DNA and RNA analysis - Multi-Omics. Our partnership with Ocean Genomics, Inc., and our team at Geneyx Genomex Ltd. are proud to release 𝐒𝐕𝐃𝐮𝐨™, a solution designed to transform how we detect genomic variants in both research and clinical genomics. This new platform lets scientists and clinicians uncover and understanf complex variants that were previously undetectable, opening doors to a deeper understanding of disease and potential treatments that so many people are the world are waiting for. 🧬💡 A heartfelt thank you to our amazing global team – your hard work has made this possible! 🌍👏🙌 Dr. Ayesha N. Shajahan-Haq, from Georgetown University's Lombardi Comprehensive Cancer Center, captures this excitement best, “The ability to accurately detect structural variants by integrating DNA and RNA analysis is transformative. SVDuo™ reveals previously undetectable variants, offering new insights into disease mechanisms and potential therapeutic targets.” Read the full story here 👇 https://lnkd.in/dxPWCFB6 #MultiOmics #DNA #RNA #GeneyxAnalysis #SVDuo

📊 The widespread availability and longevity of #FFPE samples make them invaluable in #clinicalstudies. Traditionally analyzed with bulk RNA-seq, these samples have unveiled critical insights into tumor biology and aided in identifying novel biomarkers for tumor classification, prognostics, and treatment resistance. However, bulk RNA-seq obscures cellular heterogeneity and molecular profiles of rare cell types within tumor microenvironments, potentially missing crucial biological contributors. 🔬 Challenges such as RNA crosslinking and fragmentation have limited the application of high-resolution methods like single-cell RNA sequencing. Our #randomprimer-based #M20Seq technology, alongside our #VITA Platform, provides a cutting-edge solution to access the rich information within FFPE samples at single-cell resolution. 🔎 Learn how our cutting-edge technology can enhance your research: https://lnkd.in/eaw6sGnA #scrnaseq #clinicalresearch #tumorbiology #precisionmedicine #tumorclassification #prognosticmarker #treatmentresistance

Cancer genomics with longreads? But of course! Check out our webinar on this topic.

A phenomenal new microscopy technique is transforming how we study cellular processes. Expansion in situ genome sequencing allows researchers to map DNA and proteins inside intact cells without breaking them open. This breakthrough tech provides high-resolution insights into how molecules interact, unlocking crucial data on aging, cancer, and more. 🔬 Read more about this powerful imaging tool here: https://lnkd.in/g5XcEMNE #Biotech #Genomics #CellBiology #Microscopy

Embark on a journey through multi-omics data analysis as we explore cutting-edge approaches for integrating genomic, transcriptomic, proteomic, and epigenomic data in cancer research. Learn how to leverage open-source datasets to uncover novel insights into cancer biology and therapeutic targets. Engage in hands-on activities, including gene expression profiling with GEPIA2, to deepen your understanding of multi-omics data analysis techniques and their applications in oncology. https://lnkd.in/d4-ZwvBw #cancer #multiomics #bioinformatics #omics

Explore essential tools and resources for multi-omic cancer data analysis, including UALCAN, TIMER 2.0, and cBioPortal. Learn how to conduct advanced analyses of immune infiltration, differential gene expression, and genomic alterations in cancer using these user-friendly platforms. Participate in hands-on sessions to gain practical experience in navigating and interpreting multi-omic datasets, empowering you to uncover novel insights into cancer biology and therapeutics. #bioinformatics #cancer #dataanalysis #genomics #omics